DORTIQ
Dead / Abandoned — Abandoned — no statement of use filed (as of 04 Jan 2021)
What this means for you
This application is over — abandoned 04 Jan 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87684078
- Mark type
- Stylized text
- Filed
- 14 Nov 2017
- Published for opposition
- 03 Apr 2018
- Abandoned
- 04 Jan 2021
- Attorney of record
- Kimberly Jarman, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of diseases and conditions, including ocular diseases, namely, uveitis, retinal vein occlusion, macular edema, macular disease, retinal disease, and glaucoma and diseases and conditions in joints, namely, osteoarthritis, bursitis, fibrotic diseases, and infections
- Class 010 — Medical apparatus: Sustained drug delivery systems for pharmaceuticals
Owner
- EYEPOINT PHARMACEUTICALS US, INC., WATERTOWN, MA, US
- pSivida US, Inc., Watertown, MA, US
- pSivida US, Inc., Watertown, MA, US
Prosecution history
- 04 Jan 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 04 Jan 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 29 Oct 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Oct 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Oct 2020 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 Oct 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Oct 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Oct 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 Feb 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Feb 2020 — SOU EXTENSION 4 GRANTED
- 26 Feb 2020 — SOU EXTENSION 4 FILED
- 26 Feb 2020 — SOU TEAS EXTENSION RECEIVED
- 23 Aug 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Aug 2019 — SOU EXTENSION 3 GRANTED
- 21 Aug 2019 — SOU EXTENSION 3 FILED